XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses    
Research and development $ 6,887 $ 2,745
General and administrative 2,162 2,575
Total operating expenses 9,049 5,320
Financing income, net (317) (216)
Loss before taxes 8,732 5,104
Taxes on income 21 0
Net loss for the year $ 8,753 $ 5,104
Basic loss per Ordinary Share [1] $ 0.04 $ 0.022
Diluted loss per Ordinary Share [1] $ 0.04 $ 0.022
Weighted average number of Ordinary Shares outstanding, basic [1] 220,996,240 228,090,300
Weighted average number of Ordinary Shares outstanding, diluted [1] 220,996,240 228,090,300
[1] 20 Ordinary Shares are equal to 1 American Depositary Share (ADS).